NCT06254664 - Open Label Study to Assess the Effect of Patient Use and Robustness of Tiotropium 18ug Inhalation Powder, Hard Capsule,Zephir Inhaler Device | Biotech Hunter

Enrollment

116

Participants

Timeline

Start Date

October 3, 2022

Primary Completion Date

July 7, 2023

Study Completion Date

October 27, 2023

Conditions

COPD

Interventions

DRUG

Tiotropium 18 µg inhalation powder, hard capsule

Tiotropium 18 µg administered using Zephir inhaler

DEVICE

Zephir inhaler

Tiotropium 18 µg administered using Zephir inhaler

Trial Locations (9)

Clintex Research Group, Miami

My Preferred Research LLC, Miami

Research Institute of South Florida, Inc., Miami

Vista Health Research, Miami

Vanguard Clinical Research, LLC, Fort Myers

Clinical Research Solutions - Orlando, Kissimmee

Inquest Clinical Research, LL, Cypress

Cliantha Research, Ahmedabad

Greater Providence Clinical Research, LLC, Cranston